Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature

David Green, K. J. Friedman

Research output: Contribution to journalArticle

Abstract

Cutaneous pigmentation associated with minocycline ingestion is an unusual adverse effect for which few treatments have been described. Within the past few years, treatment with different Q-switched lasers has been reported in the literature. The purpose of this therapeutic intervention was to determine whether the Q-switched Alexandrite laser could clinically and histologically improve pigmentation associated with minocycline ingestion. A patient with type II minocycline pigmentation was treated with the Q-switched Alexandrite (755 nm) laser and then evaluated clinically and histologically to determine the outcome of this intervention. Treatment with the Q-switched Alexandrite (755 nm) laser provided excellent clinical and histologic clearing of minocycline pigmentation. One year after completion of laser treatment, the skin has remained clinically clear with no recurrence. The Q-switched Alexandrite laser (755 nm) should be considered for treatment of type II minocycline pigmentation.

Original languageEnglish (US)
Pages (from-to)342-347
Number of pages6
JournalJournal of the American Academy of Dermatology
Volume44
Issue number2 SUPPL.
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Skin Pigmentation
Minocycline
Solid-State Lasers
Lasers
Pigmentation
Therapeutics
Eating
Recurrence
Skin

ASJC Scopus subject areas

  • Dermatology

Cite this

Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature. / Green, David; Friedman, K. J.

In: Journal of the American Academy of Dermatology, Vol. 44, No. 2 SUPPL., 01.01.2001, p. 342-347.

Research output: Contribution to journalArticle

@article{7df8f49ade38443bbf0177a044c450be,
title = "Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature",
abstract = "Cutaneous pigmentation associated with minocycline ingestion is an unusual adverse effect for which few treatments have been described. Within the past few years, treatment with different Q-switched lasers has been reported in the literature. The purpose of this therapeutic intervention was to determine whether the Q-switched Alexandrite laser could clinically and histologically improve pigmentation associated with minocycline ingestion. A patient with type II minocycline pigmentation was treated with the Q-switched Alexandrite (755 nm) laser and then evaluated clinically and histologically to determine the outcome of this intervention. Treatment with the Q-switched Alexandrite (755 nm) laser provided excellent clinical and histologic clearing of minocycline pigmentation. One year after completion of laser treatment, the skin has remained clinically clear with no recurrence. The Q-switched Alexandrite laser (755 nm) should be considered for treatment of type II minocycline pigmentation.",
author = "David Green and Friedman, {K. J.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1067/mjd.2001.103036",
language = "English (US)",
volume = "44",
pages = "342--347",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "2 SUPPL.",

}

TY - JOUR

T1 - Treatment of minocycline-induced cutaneous pigmentation with the Q-switched Alexandrite laser and a review of the literature

AU - Green, David

AU - Friedman, K. J.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Cutaneous pigmentation associated with minocycline ingestion is an unusual adverse effect for which few treatments have been described. Within the past few years, treatment with different Q-switched lasers has been reported in the literature. The purpose of this therapeutic intervention was to determine whether the Q-switched Alexandrite laser could clinically and histologically improve pigmentation associated with minocycline ingestion. A patient with type II minocycline pigmentation was treated with the Q-switched Alexandrite (755 nm) laser and then evaluated clinically and histologically to determine the outcome of this intervention. Treatment with the Q-switched Alexandrite (755 nm) laser provided excellent clinical and histologic clearing of minocycline pigmentation. One year after completion of laser treatment, the skin has remained clinically clear with no recurrence. The Q-switched Alexandrite laser (755 nm) should be considered for treatment of type II minocycline pigmentation.

AB - Cutaneous pigmentation associated with minocycline ingestion is an unusual adverse effect for which few treatments have been described. Within the past few years, treatment with different Q-switched lasers has been reported in the literature. The purpose of this therapeutic intervention was to determine whether the Q-switched Alexandrite laser could clinically and histologically improve pigmentation associated with minocycline ingestion. A patient with type II minocycline pigmentation was treated with the Q-switched Alexandrite (755 nm) laser and then evaluated clinically and histologically to determine the outcome of this intervention. Treatment with the Q-switched Alexandrite (755 nm) laser provided excellent clinical and histologic clearing of minocycline pigmentation. One year after completion of laser treatment, the skin has remained clinically clear with no recurrence. The Q-switched Alexandrite laser (755 nm) should be considered for treatment of type II minocycline pigmentation.

UR - http://www.scopus.com/inward/record.url?scp=0035118527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035118527&partnerID=8YFLogxK

U2 - 10.1067/mjd.2001.103036

DO - 10.1067/mjd.2001.103036

M3 - Article

C2 - 11174411

AN - SCOPUS:0035118527

VL - 44

SP - 342

EP - 347

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 2 SUPPL.

ER -